• David Yocum

Stock Chart of the Week - 7/18/22 to 7/22/22

$HALO (Halozyme Therapeutics) is up roughly 22% YTD heavily outperforming the S&P 500 which is down around 19% YTD. This name has steadily held its weekly 8/21 EMAs which price found a bounce off of last Thursday. Price also was able to hold this breakout area on the first retest. It is important to the large volume seen a couple weeks back on the large move to relative new highs. Daily Chart:

IBD Rankings Composite: 97

EPS Rating: 45 RS Rating: 97

SMR Rating: A Overall, I love this trend on the daily and weekly timeframes. This initial retest offers a nice risk reward with a potential stop being below that price area. If a push higher is given, a trailing 8 or 21 EMA stop loss could keep you in a good trade should a strong uptrend form.


Recent Posts

See All